EUS引导胆囊引流与内镜下经乳头胆囊引流治疗高危手术候选者结石性胆囊炎的长期结局比较:一项多中心倾向评分匹配分析
本研究纳入379例高危手术候选者的急性结石性胆囊炎患者,比较EUS引导胆囊引流(EUS-GBD)与内镜下经乳头胆囊引流(ETGBD)的长期疗效。倾向评分匹配后显示,EUS-GBD技术成功率显著更高(96.7% vs 78.9%,P < .001),晚期症状性不良事件率显著更低(1.3% vs 13.4%,P = .006),总体晚期不良事件率也显著更低(5.0% vs 16.4%,P = .029)。作者认为EUS-GBD长期支架置入是限制晚期不良事件的潜在选择。
要点
- EUS-GBD技术成功率显著高于ETGBD(96.7% vs 78.9%,P < .001)。
- EUS-GBD晚期症状性不良事件率显著低于ETGBD(1.3% vs 13.4%,P = .006)。
- EUS-GBD与晚期不良事件时间延长显著相关(HR .26,95%CI .10-.67,P = .005)。
核心结论
- EUS-GBD长期支架置入是限制高危手术候选者结石性胆囊炎晚期不良事件(包括复发)的潜在有前景的选择。
研究设计与样本
- 多中心倾向评分匹配分析,纳入379例符合入组标准的高危手术候选者急性结石性胆囊炎患者。
- 两组均置入塑料支架,且均未进行计划性支架更换或移除。
主要发现
- EUS-GBD技术成功率显著高于ETGBD(96.7% vs 78.9%,P < .001)。
- 早期不良事件率两组无显著差异(7.8% vs 8.9%,P = 1.000)。
- 复发性胆囊炎率两组无显著差异(3.8% vs 3.0%,P = 1.000)。
- EUS-GBD晚期症状性不良事件(除胆囊炎外)率显著低于ETGBD(1.3% vs 13.4%,P = .006)。
- EUS-GBD总体晚期不良事件率显著低于ETGBD(5.0% vs 16.4%,P = .029)。
关键数值与推荐
- 多因素分析显示EUS-GBD与晚期不良事件时间显著延长相关(HR .26,95%CI .10-.67,P = .005)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Although long-term stent placement using endoscopic transpapillary gallbladder drainage (ETGBD) and EUS-guided gallbladder drainage (EUS-GBD) reportedly reduces cholecystitis recurrence, comparative evidence of their safety and efficacy is scarce. This study aimed to examine and compare the long-term utility of EUS-GBD versus that of ETGBD in poor surgical candidates. METHODS: A total of 379 high-risk surgical patients with acute calculous cholecystitis met the eligibility criteria for enrollment in this study. The technical success and adverse events (AEs) were compared between the EUS-GBD and ETGBD groups, and propensity score matching was performed to adjust for differences between the groups. Both groups underwent plastic stent placement, and scheduled stent exchange and removal were not performed in either group. RESULTS: The technical success rate of EUS-GBD was significantly higher than that of ETGBD (96.7% vs 78.9%, P < .001), whereas the early AE rate did not differ significantly between the 2 methods (7.8% vs 8.9%, P = 1.000). The rate of recurrent cholecystitis did not differ significantly (3.8% vs 3.0%, P = 1.000), but the rate of symptomatic late AEs, in addition to cholecystitis, was significantly lower with EUS-GBD than with ETGBD (1.3% vs 13.4%, P = .006). Consequently, the overall late AE rate was significantly lower with EUS-GBD (5.0% vs 16.4%, P = .029). Multivariate analysis revealed that EUS-GBD was associated with a significantly longer time to late AE (hazard ratio, .26; 95% confidence interval, .10-.67; P = .005). CONCLUSIONS: Long-term stent placement via EUS-GBD is a promising potential option for limiting late AEs, including recurrence, in poor surgical candidates with calculous cholecystitis.
引用
- Inoue T, Yoshida M, Suzuki Y, et al. Comparison of the long-term outcomes of EUS-guided gallbladder drainage and endoscopic transpapillary gallbladder drainage for calculous cholecystitis in poor surgical candidates: a multicenter propensity score-matched analysis. Gastrointest Endosc. 2023. PMID: 37059367. doi:10.1016/j.gie.2023.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。